Journal of Alzheimer's Disease
Efficacy and safety of aducanumab, lecanemab, and donanemab in Alzheimer's disease: A meta-analysis of randomized controlled trials
Meta-analysis of randomised trialsInterventions
- Anti-amyloid monoclonal antibodies
- Alzheimer's disease
- Alzheimer's Disease Assessment Scale-Cognitive Subscale
- Clinical Dementia Rating Sum of Boxes
- Mini-Mental State Examination
- Humans
The paper
Cleveland Clinic Florida
Journal of Alzheimer's Disease, 28 Sep 2026
